Ketoacids and the insulin receptor.

Area of Science:

• Endocrinology
• Metabolic Disorders
• Molecular Biology

Background:

• Diabetic ketoacidosis (DKA) is a serious complication of diabetes characterized by hyperglycemia, acidosis, and ketosis.
• Insulin resistance is a hallmark of DKA, but the precise mechanisms affecting insulin-receptor interactions remain unclear.
• Understanding how acidosis impacts insulin signaling is crucial for managing DKA and improving glycemic control.

Purpose of the Study:

• To investigate the effect of simulated diabetic ketoacidosis conditions on insulin binding to its receptor.
• To determine if ketoacids can counteract the negative effects of acidosis on insulin-receptor binding.

Main Methods:

• In vitro study using IM-9 cultured human lymphocytes.
• Incubation of lymphocytes under varying pH conditions (7.4, 7.1, 6.8) simulating acidosis.
• Addition of beta-hydroxybutyrate to assess its effect on insulin binding.

Main Results:

• Insulin binding to its receptor significantly decreased as pH lowered (19% at pH 7.1, 48% at pH 6.8).
• Beta-hydroxybutyrate, at clinically relevant concentrations, restored insulin binding towards normal levels.
• These findings demonstrate that ketoacids can mitigate the inhibitory effects of acidosis on insulin-receptor interactions.

Conclusions:

• Acidosis in diabetic ketoacidosis impairs insulin-receptor binding.
• Ketoacids play a protective role by counteracting the effects of acidosis, thereby maintaining insulin sensitivity.
• In vivo molecules like ketoacids can modulate hormone-receptor interactions, offering insights into DKA pathophysiology.